Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.

Nature
Markus HoffmannStefan Pöhlmann

Abstract

The coronavirus disease 2019 (COVID-19) pandemic, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been associated with more than 780,000 deaths worldwide (as of 20 August 2020). To develop antiviral interventions quickly, drugs used for the treatment of unrelated diseases are currently being repurposed to treat COVID-19. Chloroquine is an anti-malaria drug that is used for the treatment of COVID-19 as it inhibits the spread of SARS-CoV-2 in the African green monkey kidney-derived cell line Vero1-3. Here we show that engineered expression of TMPRSS2, a cellular protease that activates SARS-CoV-2 for entry into lung cells4, renders SARS-CoV-2 infection of Vero cells insensitive to chloroquine. Moreover, we report that chloroquine does not block infection with SARS-CoV-2 in the TMPRSS2-expressing human lung cell line Calu-3. These results indicate that chloroquine targets a pathway for viral activation that is not active in lung cells and is unlikely to protect against the spread of SARS-CoV-2 in and between patients.

References

Jul 17, 2007·International Journal of Antimicrobial Agents·Jean-Marc RolainDidier Raoult
Nov 19, 2008·Virology Journal·Petra HerzogMarcel A Müller
Feb 11, 2015·Antiviral Research·Yanchen ZhouGraham Simmons
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Jung-Eun ParkTom Gallagher
Mar 10, 2020·Antiviral Research·Franck Touret, Xavier de Lamballerie
Mar 10, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Xueting YaoDongyang Liu
Mar 14, 2020·Proceedings of the National Academy of Sciences of the United States of America·Shutoku MatsuyamaMakoto Takeda
Apr 10, 2020·BMJ : British Medical Journal·Robin E Ferner, Jeffrey K Aronson
Jun 4, 2020·The New England Journal of Medicine·David R BoulwareKathy H Hullsiek
Jun 13, 2020·Science·Kai Kupferschmidt

❮ Previous
Next ❯

Citations

Sep 3, 2020·Nanomedicine·Georgia Wilson JonesBengt Fadeel
Aug 8, 2020·Annals of the Rheumatic Diseases·Manuel Francisco Ugarte-GilJeffrey A Sparks
Sep 25, 2020·Antioxidants·Christina B Klouda, William L Stone
Oct 8, 2020·Nature Reviews. Microbiology·Jennifer E JonesSeema S Lakdawala
Nov 10, 2020·JAMA : the Journal of the American Medical Association·Wesley H SelfDeborah Diercks
Nov 19, 2020·Future Microbiology·Antonio CassoneRoberto Cauda
Dec 4, 2020·Expert Review of Anti-infective Therapy·Divakar Sharma, Adinarayana Kunamneni
Dec 4, 2020·Microorganisms·Matteo GasbarriValeria Cagno
Dec 8, 2020·Annals of Internal Medicine·Ruanne V BarnabasUNKNOWN Hydroxychloroquine COVID-19 PEP Study Team
Jan 6, 2021·Emerging Microbes & Infections·Zhenyu ZhaoYong Lin
Jan 14, 2021·Journal of Biomedical Science·Ioannis P TrougakosMeletios A Dimopoulos
Nov 24, 2020·British Journal of Clinical Pharmacology·Venkatesh Pilla ReddyAmin Rastomi-Hodjegan
Oct 24, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Nicola ClementiAntonio Filippini
Jan 31, 2021·Applied Microbiology and Biotechnology·Amin GasmiGeir Bjørklund
Dec 31, 2020·Journal of Molecular Cell Biology·Hui YangFajian Hou
Feb 12, 2021·ACS Infectious Diseases·Kas SteutenMatthew Bogyo
Jan 19, 2021·3 Biotech·Naun Lobo-GaloEduardo Ruiz-Bustos
Dec 29, 2020·Frontiers in Pharmacology·Nour K YounisMariam Arabi
Jan 7, 2021·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Bhavesh D KevadiyaHoward E Gendelman
Nov 5, 2020·Biomedicines·Alessandro MatareseGaetano Santulli
Dec 12, 2020·Pharmaceuticals·Kenana Al AdemSungmun Lee
Dec 31, 2020·Cells·Maksim V BaranovGeert van den Bogaart
Jan 6, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·David M StevensStephan T Stern
Jan 29, 2021·Aging Clinical and Experimental Research·Paolo AgostinisAldo Baritussio
Feb 9, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Dengke TianWenqiang Cao
Nov 24, 2020·Critical Care Explorations·Heike Hofmann-WinklerMartin Sebastian Winkler
Dec 19, 2020·Open Medicine·Ruoqi NingHaiying Sun
Dec 29, 2020·Expert Review of Clinical Immunology·Philippe GautretDidier Raoult
Jan 6, 2021·Nature Reviews. Immunology·Oliver Harschnitz, Lorenz Studer
Feb 13, 2021·Nature Communications·Yunkai ZhuRong Zhang
Oct 9, 2020·Biochemical and Biophysical Research Communications·Ernesto Carafoli
Feb 27, 2021·Expert Opinion on Pharmacotherapy·María Del Mar GutierrezPere Domingo
Mar 6, 2021·Chemical Society Reviews·Mauro Sousa de AlmeidaBarbara Rothen-Rutishauser
Feb 23, 2021·Frontiers in Immunology·Ching-Hsuan LiuLiang-Tzung Lin
Feb 25, 2021·European Journal of Preventive Cardiology·Fariba AhmadizarBruno H Stricker

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

GraphPad Prism
LightCycler 480
Hidex

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

International Journal of Antimicrobial Agents
Philippe ColsonDidier Raoult
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Nicholas Moore
© 2021 Meta ULC. All rights reserved